<
 / Physicians

Product Change: Medroxyprogesterone Acetate 150 mg/mL injectable suspension (Depo-Provera)

Date

The Issue: Due to the shortage of medroxyprogesterone acetate 150 mg/mL injectable suspension (vials) in Canada, Health Canada has approved the importation of US-labelled pre-filled syringes from Pfizer in order to prevent supply gaps until Canadian product is available again (likely mid 2022).

Clinical Use: Medroxyprogesterone acetate injectable suspension is mainly used as a contraceptive.

Further information and practice implications

Share this page